BioSpace News Archive

Policy

FDA Roundup: November 14, 2023

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

November 14, 2023
·
5 min read
Biotech Bay

Codexis to Participate in 35th Annual Piper Sandler Healthcare Conference

Codexis, Inc., a leading enzyme engineering company, announced the Company will attend the 35th Annual Piper Sandler Healthcare Conference, being held November 28-30, 2023, in New York, New York.

November 14, 2023
·
1 min read
Business

TFF Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

TFF Pharmaceuticals, Inc. reported financial results for the third quarter of 2023 and provided a corporate update.

November 14, 2023
·
10 min read
Business

Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results

Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the third quarter ended September 30, 2023.

November 14, 2023
·
8 min read
Biotech Bay

Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare Conference

Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming Piper Sandler 35th Annual Healthcare Conference in New York, New York.

November 14, 2023
·
2 min read
Business

STRATA Skin Sciences Reports Third Quarter 2023 RevenueCompany to Host Conference Call and Webcast Today, November 14, 2023, at 4:30 PM ET

STRATA Skin Sciences, Inc. announced financial results for the third quarter ended September 30, 2023.

November 14, 2023
·
12 min read
Business

Mustang Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

Mustang Bio, Inc. (“Mustang”) (Nasdaq: MBIO) today announced financial results and recent corporate highlights for the third quarter that ended September 30, 2023.

November 14, 2023
·
16 min read
Business

Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update

Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS) today reported financial results and operating highlights for the third quarter and nine months ended September 30, 2023.

November 14, 2023
·
14 min read
Business

Reviva Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”) today reported financial results for the third quarter ended September 30, 2023 and summarized recent business highlights.

November 14, 2023
·
10 min read
Genetown

Solid Biosciences Announces IND Clearance by FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003

Solid Biosciences Inc. (Nasdaq: SLDB) today announced that it has received U.S. Food and Drug Administration (FDA) clearance of an Investigational New Drug (IND) application for SGT-003, the company’s next-generation Duchenne Muscular Dystrophy (Duchenne) gene therapy candidate.

November 14, 2023
·
6 min read